EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression of progesterone by influenza A virus mediates adverse maternal and fetal outcomes in mice

Patrick S Creisher, Maclaine A Parish, Jun Lei, Jin Liu, Jamie L Perry, Ariana D Campbell, Morgan L Sherer, Irina Burd, Sabra L Klein iD

mBio · 2024

DOI: 10.1128/mbio.03065-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Patrick S Creisher und 8 weiteren Autor:innen. Beteiligte Einrichtung: W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Influenza A virus, Influenza, Human, Influenza A Virus, H1N1 Subtype. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIA NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pregnant individuals are at risk of severe outcomes from both seasonal and pandemic influenza A viruses. Influenza infection during pregnancy is associated with adverse fetal outcomes at birth and adverse consequences for offspring into adulthood. When outbred dams, with semi-allogenic fetuses, were infected with 2009 H1N1, in addition to pulmonary virus replication, lung damage, and inflammation, the placenta showed evidence of transient cell death and inflammation that was mediated by increased activity along the arachidonic acid pathway leading to suppression of circulating progesterone. Placental damage and suppressed progesterone were associated with detrimental effects on perinatal growth and developmental delays in offspring. Treatment of H1N1-infected pregnant mice with 17-OHPC, a synthetic progestin treatment that is safe to use in pregnancy, prevented placental damage and inflammation and adverse fetal outcomes. This novel therapeutic option for the treatment of influenza during pregnancy should be explored clinically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A virusInfluenza, HumanInfluenza A Virus, H1N1 SubtypePregnancyFemaleMiceAnimalsHumansProgesteronePlacentaInflammationFetus

Stichwörter der Autor:innen

cytokine stormmacrophagesplacentapregnancyprogestinsprostaglandins

Substanzen

Progesterone

Autor:innen und Institutionen

  • W. Harry Feinstone Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Obstetrics, Gynecology & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Department of Gynecology and Obstetrics, Integrated Research Center for Fetal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Sabra L Klein

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • NICHD NIH HHS
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Creisher, P. S., Parish, M. A., Lei, J., Liu, J., Perry, J. L., Campbell, A. D., Sherer, M. L., Burd, I., & Klein, S. L. (2024). Suppression of progesterone by influenza A virus mediates adverse maternal and fetal outcomes in mice. mBio. https://doi.org/10.1128/mbio.03065-23

Vancouver

Creisher PS, Parish MA, Lei J, Liu J, Perry JL, Campbell AD, et al. Suppression of progesterone by influenza A virus mediates adverse maternal and fetal outcomes in mice. mBio. 2024. doi:10.1128/mbio.03065-23

BibTeX
@article{Creisher2024,
  author = {Creisher, Patrick S and Parish, Maclaine A and Lei, Jun and Liu, Jin and Perry, Jamie L and Campbell, Ariana D and Sherer, Morgan L and Burd, Irina and Klein, Sabra L},
  title = {Suppression of progesterone by influenza A virus mediates adverse maternal and fetal outcomes in mice},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.03065-23}
}
Kostenlos starten →